WO2012148481A1 - Compositions containing polyhydroxyoxoaluminum cations and manufacture thereof - Google Patents

Compositions containing polyhydroxyoxoaluminum cations and manufacture thereof Download PDF

Info

Publication number
WO2012148481A1
WO2012148481A1 PCT/US2011/066018 US2011066018W WO2012148481A1 WO 2012148481 A1 WO2012148481 A1 WO 2012148481A1 US 2011066018 W US2011066018 W US 2011066018W WO 2012148481 A1 WO2012148481 A1 WO 2012148481A1
Authority
WO
WIPO (PCT)
Prior art keywords
aluminum
nmr
buffer
ppm
molar ratio
Prior art date
Application number
PCT/US2011/066018
Other languages
French (fr)
Inventor
John Vaughn
Iraklis Pappas
Long Pan
Original Assignee
Colgate-Palmolive Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate-Palmolive Company filed Critical Colgate-Palmolive Company
Priority to MX2013012371A priority Critical patent/MX361821B/en
Priority to ES11810736.6T priority patent/ES2569856T3/en
Priority to BR112013024919A priority patent/BR112013024919A2/en
Priority to US14/110,723 priority patent/US9174851B2/en
Priority to CA2834129A priority patent/CA2834129A1/en
Priority to EP11810736.6A priority patent/EP2702008B1/en
Priority to AU2011366871A priority patent/AU2011366871B2/en
Priority to RU2013152256/05A priority patent/RU2013152256A/en
Publication of WO2012148481A1 publication Critical patent/WO2012148481A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01FCOMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F7/00Compounds of aluminium
    • C01F7/02Aluminium oxide; Aluminium hydroxide; Aluminates
    • C01F7/021After-treatment of oxides or hydroxides
    • C01F7/026Making or stabilising dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28Zirconium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01FCOMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F7/00Compounds of aluminium
    • C01F7/48Halides, with or without other cations besides aluminium
    • C01F7/56Chlorides
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01FCOMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F7/00Compounds of aluminium
    • C01F7/78Compounds containing aluminium and two or more other elements, with the exception of oxygen and hydrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58Metal complex; Coordination compounds
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/80Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
    • C01P2002/86Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by NMR- or ESR-data
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/80Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
    • C01P2002/87Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by chromatography data, e.g. HPLC, gas chromatography

Definitions

  • the present invention is directed to compositions containing polyhydroxyoxoaluminum cations and manufacture thereof. These aluminum materials can be used for antiperspirant salts, water treatment, wastewater treatment, dye mordants, taste astringents, and clay pillaring.
  • ZAG ZAG complexes
  • AZG ZAG complexes
  • AI13 is composed of 12 octahedrally coordinated Al atoms surrounded by one centrally-cited Al atom which is tetrahedrally coordinated.
  • the AI30 polyhydroxyoxoaluminum cation is essentially a dimer of the AI13 polyhydroxyoxoaluminum cation and contains 2 tetrahedrally coordinated Al atoms which resonate at 70 ppm.
  • Al NMR spectroscopy may not fully elucidate the chemical composition of a partially neutralized Al salt solution, since there may be a variety of Al species that do not give rise to sharp and unambiguous resonance peaks. These species can be considered
  • Figure 1 is a 27 Al NMR spectrograph of material 1 from the examples before heating.
  • composition comprising a
  • polyhydroxyoxoaluminum cation ii) an inorganic salt, and iii) a buffer, wherein the buffer is at least one of an amino acid, betaine, and quat, and a molar ratio of buffer to aluminum is at least 0.1 : 1, wherein the heating is one of
  • the buffer is glycine.
  • the inorganic salt is at least one chloride salt chosen from calcium chloride, magnesium chloride, strontium chloride, barium chloride, stannous chloride, and yttrium chloride.
  • the inorganic base includes at least one member chosen from calcium hydroxide, magnesium hydroxide, strontium hydroxide, barium hydroxide, stannous hydroxide, yttrium hydroxide, calcium oxide, magnesium oxide, strontium oxide, barium oxide, stannous oxide, yttrium oxide, calcium carbonate, magnesium carbonate, strontium carbonate, barium carbonate, stannous carbonate, and yttrium carbonate.
  • the inorganic base is calcium hydroxide.
  • the inorganic base is calcium hydroxide.
  • the first aluminum salt is an aluminum chloride compound chosen from aluminum trichloride, aluminum chlorohexahydrate, aluminum dichlorohydrate, and aluminum monochlorohydrate.
  • the composition further comprises zirconium.
  • the zirconium compound may be ZrOCl 2 -8H 2 0 or Oxo-Hexameric Zirconium-Octaamino Acid.
  • the present invention further provides a composition produced by the method of the invention or the use of the invention.
  • Al NMR visible species that have known structures, such as AI13 and AI30
  • the inorganic salt and buffer help to stabilize the species of polyhydroxyoxoaluminum
  • the inorganic salt is at least one chloride salt chosen from calcium chloride, strontium chloride, barium chloride, magnesium chloride, stannous chloride, and yttrium chloride.
  • the salt is calcium chloride.
  • the buffer is glycine. In certain embodiments, the inorganic salt is calcium chloride and the buffer is glycine.
  • the Al 30 containing compositions may be made in a variety of ways involving a stepwise procedure to neutralize aluminum chloride in solution (optionally buffered) using inorganic basic salts.
  • the procedure generally includes the step of heating an aqueous solution containing an aluminum chloride compound (optionally with a buffer agent) at a temperature of 50°C to 100°C, optionally 50°C to 95°C, for a period of time of 1 hour to 6 hours.
  • the heating may be under stirring, such as vigorous stirring, or under reflux.
  • an aqueous solution containing an aluminum chloride compound and a buffer agent is heated at a temperature of 75°C to 95°C to reflux for a period of time of 2 hours to 4 hours.
  • the temperature is 95°C under vigorous stirring for a period of time of 2.5 hours.
  • an aqueous solution of an inorganic base is added to the heated solution to thereby obtain a pH adjusted aluminum salt solution having a hydroxide to aluminum molar ratio of 1 : 1 to 4 : 1 , and a pH of 2 to 5.
  • the hydroxide to aluminum molar ratio of 2: 1 to 3 1.
  • the hydroxide to aluminum molar ratio is 2.1 : 1 to 2.6: 1.
  • the inorganic base can be at least one base chosen from metal hydroxides, calcium hydroxide, magnesium hydroxide, strontium hydroxide, barium hydroxide, stannous hydroxide, yttrium hydroxide, calcium oxide, magnesium oxide, strontium oxide, barium oxide, stannous oxide, yttrium oxide, calcium carbonate, magnesium carbonate, strontium carbonate, barium carbonate, stannous carbonate, and yttrium carbonate.
  • metal hydroxides calcium hydroxide, magnesium hydroxide, strontium hydroxide, barium hydroxide, stannous hydroxide, yttrium hydroxide, calcium oxide, magnesium oxide, strontium oxide, barium oxide, stannous oxide, yttrium oxide, calcium carbonate, magnesium carbonate, strontium carbonate, barium carbonate, stannous carbonate, and yttrium carbonate.
  • the inorganic base is calcium hydroxide.
  • the addition of calcium hydroxide provides an aqueous solution having a Ca(OH) 2 : glycine molar ratio of at least 0.1 : 1.
  • the present invention provides for aluminum compositions and/or aluminum-zirconium compositions having high levels of low molecular weight Al and Zr species.
  • the high levels of low molecular weight Al and Zr species is reflected in a SEC trace that has an intense Peak 4 and low Peaks 1, 2, 3 and 5.
  • the polymerization of the aluminum species in aqueous solutions and the correspondent gelation process are followed by monitoring the molecular weight profile of the polyoxohalides in time by SEC.
  • the relative retention time (“Kd”) for each of these peaks varies depending on the experimental conditions, but the peaks remain relative to each other.
  • fpi is the fraction of peak i
  • Pi or Pj are the intensity of peaks Pi or Pj, respectively.
  • the amount of low molecular weight Al species will be correlated with the fraction, f P4 , or percentage, f P4 xlOO, of SEC-Peak 4.
  • a preferred aluminum species would have a very low fpi , fp2, fp3, and/or f P5 , and a high f P4 .
  • the ratio of Peak 4 to Peak 3 is at least 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, or any number up to infinity.
  • Peak 3 is so low as to be undetectable.
  • an aluminum salt and/or aluminum-zirconium salt, in aqueous solution exhibit a SEC profile wherein the SEC Peak 4 to Peak 3 intensity ratio is even as high as infinity, because the Peak 3 is undetectable.
  • the percentage of SEC Peak 4 of a total area of Peaks 1, 2, 3, 4 and 5 in the SEC chromatogram is: at least at least 90%; at least 95%, or 95 to 100%. In another such embodiment, the SEC Peak 4 area is 100%.
  • the aluminum salt and/or the aluminum-zirconium salt, in aqueous solution exhibits a SEC profile which exhibits a low percentage of SEC Peak 1 and a low percentage of SEC Peak 2.
  • the percentage of SEC Peak 1 area of a total area of Peaks 1, 2, 3, 4 and 5 in the SEC chromatogram is less than 5 %; less than 2 %; or less than 1 %, or the salt has no SEC Peak 1 area.
  • the percentage of SEC Peak 2 area of a total area of Peaks 1, 2, 3, 4 and 5 in the SEC chromatogram is less than 5 %; less than 2 % or less than 1 %; or the salt has no SEC Peak 2 area.
  • compositions of this invention may be used to formulate many different aluminum containing materials. Examples include, but are not limited to, antiperspirant salts, water treatment, wastewater treatment, and clay pillaring.
  • Two materials prepared in accordance with PCT/US2010/55030 are provided.
  • the materials are aqueous systems that contain the glycine buffer and the calcium chloride byproduct of the manufacturing process.
  • Material 1 is held at reflux for 30 days at 100°C.
  • Material 2 is subjected to 100°C for 5 days in an isochoric reaction vessel.
  • the following discussion relates only with the relative integrations instead of raw data.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Geology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A composition comprising a polyhydroxyoxoaluminum cation detectable at 76 ppm by 27Al NMR that is present in a relative abundance on a 27Al NMR spectrograph that is greater than any other polyhydroxyoxoaluminum cation detectable by 27Al NMR. Also, disclosed are methods of making the composition.

Description

COMPOSITIONS CONTAINING POLYHYDROXYOXO ALUMINUM CATIONS AND
MANUFACTURE THEREOF CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority to U.S. Provisional Patent Application No. 61/479,081, filed 26 April 2011, which is incorporated herein by reference.
FIELD OF THE INVENTION
[0002] The present invention is directed to compositions containing polyhydroxyoxoaluminum cations and manufacture thereof. These aluminum materials can be used for antiperspirant salts, water treatment, wastewater treatment, dye mordants, taste astringents, and clay pillaring.
BACKGROUND OF THE INVENTION
[0003] Aluminum salts, such as aluminum chlorohydrex (also called aluminum chlorohydrex polymeric salts and abbreviated here as "ACH") and aluminum zirconium glycine salts
(abbreviated here as "ZAG", "ZAG complexes" or "AZG"), are known to contain a variety of polymeric and oligomeric species with molecular weights (MW) of 100 Da - 500,000 Da.
[0004] In an attempt to increase the quality and quantity of smaller aluminum and/or zirconium species, a number of efforts have focused on: (1) how to select the components of ACH and ZAG that affect the performance of these materials; and (2) how to manipulate these components to obtain and/or maintain the presence of smaller types of these components. These attempts have included the development of analytical techniques to identify the components. Size exclusion chromatography ("SEC") or gel permeation chromatography ("GPC") are methods frequently used for obtaining information on polymer distribution in aluminum salt solutions. With appropriate chromatographic columns, generally five distinctive groups of polymer species can be detected in commercial ACH and ZAG complexes appearing in a chromatogram as peaks 1, 2, 3, 4 and a peak known as "5,6", referred to hereinafter as Peak 5. Peak 1 contains the larger Zr species (greater than 60 Angstroms). Peaks 2 and 3 contain larger aluminum species. Peak 4 contains smaller aluminum species (aluminum oligomers, or small aluminum clusters) and has been correlated with enhanced antiperspirant efficacy for both Al and Al/Zr salts. Peak 5 contains the smallest and most acidic aluminum species. Various analytical approaches for characterizing the peaks of ACH and various types of ZAG actives are found in "Antiperspirant Actives—Enhanced Efficacy Aluminum-Zirconium-Glycine (AZG) Salts" by Dr. Allan H. Rosenberg (Cosmetics and Toiletries Worldwide, Fondots, D. C. ed., Hertfordshire, UK: Aston Publishing Group, 1993, pages 252, 254-256).
[0005] Attempts to activate antiperspirant salts to produce materials having improved efficacy have included developing processes for obtaining composition having large amounts of Peak 4.
[0006] Solutions of partially neutralized aluminum are known to contain a variety of hydro lytic Al species. The identity and distribution of these various forms depends on the hydrolysis ratio (i.e. the OH:Al molar ratio), the Al precursor and the choice of the reaction condition. In the field of antiperspirant (AP) technology, SEC chromatography is the traditional method used for elucidating the distribution of these Al species. Conventional SEC physically separates Al species into domains which are subsequently measured using a concentration detector. It is generally recognized that at least five domains of Al species can be differentiated by size- exclusive chromatography. These domains are commonly referred to Peak 1, Peak 2, Peak 3, Peak 4, and Peak 5, where increasing peak number indicates smaller relative size of the eluting species. Peak 4 and Peak 5 have been implicated as highly efficacious Al domains for antiperspirants. Monomeric Al and low oligomers, are known to elute under Peak 5. Oligomeric polyhydroxyoxoaluminum cations elute under Peak 4.
[0007] It is well known in the art that such a variety of hydro lytic Al species exists and that it is possible to distinguish large aqueous aluminum hydroxide molecules using spectroscopic methods such as 27 Al NMR which elucidates the structural environment surrounding Al atoms which are embodied in various forms (Casey WH, "Large Aqueous Aluminum Hydroxide Molecules", Chem. Rev. 2006, 106 (1), pages 1 to 16).
[0008] There are two regions in a 27 Al NMR spectrum that represent Al nuclei which are octahedrally coordinated (0 ppm - 60 ppm) and tetrahedrally coordinated (60 ppm - 90 ppm). The octahedral region is exemplified by the hexa-aqua Al species, i.e. monomeric Al, which resonates sharply at 0 ppm. The tetrahedral region is exemplified by sharp resonance at 62.5 ppm from the AI13 polyhydroxyoxoaluminum cation. AI13 is composed of 12 octahedrally coordinated Al atoms surrounded by one centrally-cited Al atom which is tetrahedrally coordinated. The AI30 polyhydroxyoxoaluminum cation is essentially a dimer of the AI13 polyhydroxyoxoaluminum cation and contains 2 tetrahedrally coordinated Al atoms which resonate at 70 ppm. [0009] It is known that Al NMR spectroscopy may not fully elucidate the chemical composition of a partially neutralized Al salt solution, since there may be a variety of Al species that do not give rise to sharp and unambiguous resonance peaks. These species can be considered
27
as effectively NMR-invisible. Unless the Al NMR spectroscopy is carried out quantitatively, the relative concentration of these NMR-invisible species cannot be determined and must be inferred from SEC chromatography.
[0010] The state of the art discloses a number of methods for synthesizing and purifying the AI13 polyhydroxyoxoalummum cation (for example Fu G, et al, "Aging Processes of Alumina Sol-
27
Gels; Characterization of New Aluminum Polycations by Al NMR Spectroscopy" Chem.
Mater. 1991, 3(4), pages 602 to 610).
[0011] It is known that the AI13 polyhydroxyoxoalummum cation may be converted to obtain the AI30 polyhydroxyoxoalummum cation by heating a solution of the AI13
polyhydroxyoxoalummum cation (Roswell J et al, "Speciation and Thermal Transformation in
18+
Alumina Sols; Structures of the Polyhydroxyoxoalummum Cluster [AI30 08 (ΟΗ)56 (H20)26] and its δ-Keggin Moiete", J. Am. Chem. Soc. 2000, 122, pages 3777 to 3778; Chen Z et al, "Effect of thermal treatment on the formation and transformation of Keggin AI13 and AI30 species in hydrolytic polymeric aluminum solutions", Colloids and Surfaces A: Physiochem. Eng.
Aspects, 292 (2007) pages 110 to 118; and Allouche L et al, "Conversion of AI13 Keggin ε into AI30: a reaction controlled by aluminum monomers", Inorganic Chemistry Communications, 6 (2003) pages 1167-1170).
[0012] Heating an AI13 solution is the only synthetic pathway to achieving AI30 which has been described in the literature. As well as the references identified above, WO-A-2006/103092 and Shafran KL et al, "The static anion exchange method for generation of high purity aluminum polyoxocations and monodisperse aluminum hydroxide nano-particles", J. Mater. Chem., 2005, 15, pages 3415 to 3423, disclose the use of an ion-exchange process to synthesize AI13 to achieve greater than 90% purity, and disclose heating the thus-formed AI13 solution to form AI30.
[0013] Partial neutralization of Al salts have been shown to yield trace quantities of the polyhydroxyoxoalummum cation detectable at 76 ppm by 27 Al NMR. There is a need in the art for a high-yield synthetic route to the polyhydroxyoxoalummum cation detectable at 76 ppm by
27
Al NMR. The small quantities obtained, lack of purity, and lack of method of making has prevented science from isolating this polycation in sufficient quantity and purity so that its structure could be determined.
[0014] It would be desirable to develop a method to make a composition containing a polyhydroxyoxoalummum cation detectable at 76 ppm by 27 Al NMR in a sufficient quantity so that this cation can be analyzed for chemical structure and physical properties. Such a method could make a composition that has the polyhydroxyoxoalummum cation detectable at 76 ppm by
27 Al NMR present in a relative abundance that is greater than any other species of aluminum detectable by 27 Al NMR.
BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 is a 27 Al NMR spectrograph of material 1 from the examples before heating.
[0016] Figure 2 is a 27 Al NMR spectrograph of material 1 from the examples after heating.
[0017] Figure 3 is a 27 Al NMR spectrograph of material 2 from the examples before heating.
[0018] Figure 4 is a 27 Al NMR spectrograph of material 2 from the examples after heating.
BRIEF SUMMARY OF THE INVENTION
[0019] It has been discovered that the AI30 polyhydroxyoxoalummum cation can be converted to a species of polyhydroxyoxoalummum cation detectable at 76 ppm by 27 Al NMR. This species also will elute at Peak 4 on a SEC chromatogram. The AI30 polyhydroxyoxoalummum cation can be obtained from the inventors' earlier work, which was filed as PCT/US2010/55030 on 2 November 2011.
[0020] The previous material can be aged for a sufficient time at sufficient temperature to convert the Al30. In one embodiment, the material can be aged at about 100°C for a sufficient period of time, such as about 10 days or greater, or about 30 days or greater. In another embodiment, the material can aged by supercritical heating in an isochoric reaction vessel or under hydrothermal reaction at sufficient temperature and time, such as at 100°C for 5 days. In another embodiment, the material can be aged at ambient conditions (such as 15°C to 60°C) for a period of time of several months, such as at least 6 months, to more than one year.
[0021] The present invention accordingly provides composition comprising a
polyhydroxyoxoalummum cation detectable at 76 ppm by 27 Al NMR that is present in a relative abundance on a 27 Al NMR spectrograph that is greater than any other polyhydroxyoxoalummum cation detectable by 27 Al NMR. [0022] In some embodiments, the aluminum salt has an OH to Al ratio of at most 2.6: 1, and in other embodiments 2: 1 to 2.6: 1 , optionally an OH to Al ratio of 2: 1 to 2.5 : 1 , or 2.3 : 1 to 2.5 : 1.
[0023] The composition may optionally further comprise a buffer, optionally wherein a molar ratio of buffer to aluminum is at least 0.1 : 1. In other embodiments, the molar ratio is 0.1 : 1 to 3: 1. The buffer may be at least one buffer chosen from an amino acid, betaine, and quat.
Optionally, the buffer is an amino acid and a molar ratio of amino acid to aluminum is at least 0.1 : 1. In some embodiments, the amino acid is glycine.
[0024] In some embodiments, the composition has a SEC Peak 4 area of at least 95% of a total area of Peaks 1, 2, 3, 4 and 5 in the SEC chromatogram. In some embodiments, the composition has a SEC Peak 3 area of less than 5% of a total area of Peaks 1, 2, 3, 4 and 5 in the SEC chromatogram, and most preferably has no SEC Peak 3 area in the SEC chromatogram.
[0025] In some embodiments, the composition has a SEC Peak 5 area of less than 5% of a total area of Peaks 1, 2, 3, 4 and 5 in the SEC chromatogram, and most preferably has no SEC Peak 5 area in the SEC chromatogram.
[0026] In some embodiments, the composition has a SEC Peak 4 area of 95 to 100%, no SEC Peak 3 area, and a SEC Peak 5 area of from 0 to 5% of a total area of Peaks 1, 2, 3, 4 and 5 in the SEC chromatogram.
[0027] The composition may further comprise zirconium, and optionally a molar ratio of aluminum to zirconium is 5 : 1 to 10 : 1.
[0028] A method of making a polyhydroxyoxoaluminum cation detectable at 76 ppm by 27 Al NMR comprising:
heating an aqueous solution containing i) a first aluminum salt containing an AI30
polyhydroxyoxoaluminum cation, ii) an inorganic salt, and iii) a buffer, wherein the buffer is at least one of an amino acid, betaine, and quat, and a molar ratio of buffer to aluminum is at least 0.1 : 1, wherein the heating is one of
a) at a temperature of 100°C to 250°C in an isochoric reactor or under hydrothermal
reaction for a time sufficient to form a species of polyhydroxyoxoaluminum cation detectable at 76 ppm by 27 Al NMR; or
b) at 100°C at reflux for about 10 days or greater, optionally about 30 days or greater.
[0029] The present invention also provides a method of making a polyhydroxyoxoaluminum cation detectable at 76 ppm by 27 Al NMR comprising storing an aqueous solution containing i) an AI30 polyhydroxyoxoaluminum cation, ii) an inorganic salt, and iii) a buffer, wherein the buffer is at least one of an amino acid, betaine, and quat, and a molar ratio of buffer to aluminum is at least 0.1 : 1 at a temperature of 15°C to 60°C for a period of time until the
polyhydroxyoxoaluminum cation detectable at 76 ppm by 27 Al NMR that is present in a relative abundance on a 27 Al NMR spectrograph that is greater than any other polyhydroxyoxoaluminum cation detectable by 27 Al NMR.
[0030] In some embodiments, the buffer is glycine. In some embodiments, the inorganic salt is at least one chloride salt chosen from calcium chloride, magnesium chloride, strontium chloride, barium chloride, stannous chloride, and yttrium chloride. In some embodiments, the inorganic base includes at least one member chosen from calcium hydroxide, magnesium hydroxide, strontium hydroxide, barium hydroxide, stannous hydroxide, yttrium hydroxide, calcium oxide, magnesium oxide, strontium oxide, barium oxide, stannous oxide, yttrium oxide, calcium carbonate, magnesium carbonate, strontium carbonate, barium carbonate, stannous carbonate, and yttrium carbonate. Typically, the inorganic base is calcium hydroxide. In some
embodiments, the aluminum salt solution has an OH to Al molar ratio of 2.0: 1 to 2.5 : 1 or 2.1 : 1 to 2.5: 1.
[0031] In some embodiments, the first aluminum salt is an aluminum chloride compound chosen from aluminum trichloride, aluminum chlorohexahydrate, aluminum dichlorohydrate, and aluminum monochlorohydrate. Optionally, the composition further comprises zirconium. The zirconium compound may be ZrOCl2-8H20 or Oxo-Hexameric Zirconium-Octaamino Acid.
[0032] The present invention further provides the use of a heating step to convert AI30 polyhydroxyoxoaluminum cations in the species detectable by 27 Al NMR within an aqueous aluminum salt solution into a species of polyhydroxyoxoaluminum cation detectable at 76 ppm
27
by Al NMR, the heating step is one of:
a) at a temperature of 100°C to 250°C in an isochoric reactor or under hydrothermal
reaction for a time sufficient to form a species of polyhydroxyoxoaluminum cation detectable at 76 ppm by 27 Al NMR; or
b) at 100°C at reflux for about 10 days or greater, optionally about 30 days or greater.
[0033] In some embodiments, the heating step converts all the AI13 polyhydroxyoxoaluminum cation species present in the aqueous aluminum salt solution into the AI30
polyhydroxyoxoaluminum cation species. In some embodiments, the buffer is glycine. [0034] In some embodiments, the OH:Al molar ratio has been achieved by adding to the aqueous aluminum salt solution an inorganic base including at least one member chosen from calcium hydroxide, magnesium hydroxide, strontium hydroxide, barium hydroxide, stannous hydroxide, yttrium hydroxide, calcium oxide, magnesium oxide, strontium oxide, barium oxide, stannous oxide, yttrium oxide, calcium carbonate, magnesium carbonate, strontium carbonate, barium carbonate, stannous carbonate, and yttrium carbonate. Typically, the inorganic base is calcium hydroxide. Optionally, the OH to Al molar ratio is 2.0: 1 to 2.5 : 1 or 2.1 : 1 to 2.5 : 1.
[0035] In some embodiments, the aluminum salt is an aluminum chloride compound chosen from aluminum trichloride, acidified aluminum chlorohexahydrate, aluminum dichlorohydrate, and aluminum monochlorohydrate.
[0036] The present invention further provides a composition produced by the method of the invention or the use of the invention.
DETAILED DESCRIPTION OF THE INVENTION
27
[0037] In this specification, the use of Al NMR data is not quantitative but considers only NMR- visible Al species and in particular resonances at 0 ppm, 62.5 ppm, 70 ppm, and 76 ppm.
27
Octahedrally coordinated nuclei are detected via Al NMR. The Al monomer resonance at 0 ppm is octahedrally coordinated. Octahedral bands in AI13 and AI30 are broad and overlapping, so they're not useful when identifying Al species. The breadth of octahedral bands in AI13 & AI30 is due to structural and environmental variation. Because the Al nuclei in monomeric Al exist structurally in one form, the signal is narrow, and easily identified. Tetrahedrally coordinated nuclei in AI13 and AI30 also feature minimal variation, which leads to narrow,
27
identifiable NMR signals. Al NMR data do not indicate the amount of undetected Al embodied in NMR-invisible species.
[0038] When calculating the relative amounts of Al embodied in compositions containing
27
Al NMR visible species that have known structures, such as AI13 and AI30
polyhydroxyoxoaluminum cations, the tetrahedral resonance peak of the aluminum is integrated and multiplied by a scaling factor to account for other octahedrally coordinated Al present in the structure. In the AI13 polyhydroxyoxoaluminum cation, there is one tetrahedral resonance peak in the structure. In the AI30 polyhydroxyoxoaluminum cation, there are two tetrahedral resonance peaks in the structure. To convert, the resonance from the AI13
polyhydroxyoxoaluminum cation is multiplied by 13, whereas the resonance from the AI30 polyhydroxyoxoalummum cation is multiplied by 15. When the structure of the 76 ppm material is identified, a scaling factor can be determined.
[0039] For now, the amounts of each species of polyhydroxyoxoalummum cation in a composition will be characterized by the relative abundance of tetrahedral aluminum resonance peaks on a 27 Al NMR spectrograph. This means that the area of the tetrahedral aluminum resonance peak for a polyhydroxyoxoalummum cation is compared to the area of the tetrahedral aluminum resonance peaks for other polyhydroxyoxoalummum cations. The 27 Al NMR spectrograph should be collected at sufficient enough field strength so that all relevant signals
27
can be integrated. One procedure for operating a Al NMR is described in the examples below. In the current state of the art, the resonance frequency is at least 104.2 Mhz to provide a sufficient field strength.
[0040] The present invention is directed to a polyhydroxyoxoalummum cation detectable at 76 ppm by 27 Al NMR that is present in a relative abundance on a 27 Al NMR spectrograph that is greater than any other polyhydroxyoxoalummum cation detectable by 27 Al NMR. This means that there are more tetrahedral aluminum atoms resonating at 76 ppm than at any other position in the tetrahedral region of the 27 Al NMR spectrograph.
[0041] In certain embodiments, the species of polyhydroxyoxoalummum cation detectable at 76 ppm by 27 Al NMR is present in a relative abundance on a 27 Al NMR spectrograph that is at least 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 96, 97, 98, 99, 99.5, 99.9, 99.99, or 99.999% of all species of polyhydroxyoxoalummum cation detectable by 27 Al NMR.
[0042] The species of polyhydroxyoxoalummum cation detectable at 76 ppm by 27 Al NMR can be made by heating an aqueous solution containing i) an AI30 polyhydroxyoxoalummum cation, ii) an inorganic salt, and iii) a buffer, wherein the buffer is at least one of an amino acid, betaine, and quat, and a molar ratio of buffer to aluminum is at least 0.1 : 1, wherein the heating is one of a) at a temperature of 100°C to 250°C in an isochoric reactor or under hydrothermal
reaction for a time sufficient to form a species of polyhydroxyoxoalummum cation detectable at 76 ppm by 27 Al NMR;
b) at 100°C at reflux for about 10 days or greater, optionally at least 30 days or greater.
[0043] Alternatively, the species of polyhydroxyoxoalummum cation detectable at 76 ppm by
27 Al NMR can be made by storing an aqueous solution containing i) an AI30
polyhydroxyoxoalummum cation, ii) an inorganic salt, and iii) a buffer, wherein the buffer is at least one of an amino acid, betaine, and quat, and a molar ratio of buffer to aluminum is at least 0.1 :1 at a temperature of 15°C to 60°C for a period of time until the polyhydroxyoxoaluminum cation detectable at 76 ppm by 27 Al NMR that is present in a relative abundance on a 27 Al NMR spectrograph that is greater than any other polyhydroxyoxoaluminum cation detectable by 27 Al NMR. At these ambient temperatures, the time needed will be several months, such as at least 6 months, to more than one year.
[0044] The reaction in the isochoric reactor or under hydrothermal reaction is conducted at 100°C to 250°C. As the temperature increases, the time need to convert AI30
polyhydroxyoxoaluminum cation to the polyhydroxyoxoaluminum cation detectable at 76 ppm
27
by Al NMR decreases. Below are some examples of temperature and time:
i) at 100°C for about 5 days,
ii) at 120°C for about 12 hours, or
iii) at 150°C for about 20 minutes.
[0045] The inorganic salt and buffer help to stabilize the species of polyhydroxyoxoaluminum
27
cation detectable at 76 ppm by Al NMR. In certain embodiments, the inorganic salt is at least one chloride salt chosen from calcium chloride, strontium chloride, barium chloride, magnesium chloride, stannous chloride, and yttrium chloride. In one embodiment, the salt is calcium chloride. In certain embodiments, the buffer is glycine. In certain embodiments, the inorganic salt is calcium chloride and the buffer is glycine.
[0046] The description below describes methods of obtaining an Al30 polyhydroxyoxoaluminum cation containing composition.
[0047] The Al30 containing compositions may be made in a variety of ways involving a stepwise procedure to neutralize aluminum chloride in solution (optionally buffered) using inorganic basic salts. The procedure generally includes the step of heating an aqueous solution containing an aluminum chloride compound (optionally with a buffer agent) at a temperature of 50°C to 100°C, optionally 50°C to 95°C, for a period of time of 1 hour to 6 hours. The heating may be under stirring, such as vigorous stirring, or under reflux. In one such embodiment, an aqueous solution containing an aluminum chloride compound and a buffer agent is heated at a temperature of 75°C to 95°C to reflux for a period of time of 2 hours to 4 hours. In one embodiment, the temperature is 95°C under vigorous stirring for a period of time of 2.5 hours. [0048] To adjust the pH of the aluminum salt solution, an aqueous solution of an inorganic base is added to the heated solution to thereby obtain a pH adjusted aluminum salt solution having a hydroxide to aluminum molar ratio of 1 : 1 to 4 : 1 , and a pH of 2 to 5. In one such embodiment, the hydroxide to aluminum molar ratio of 2: 1 to 3 : 1. In another such embodiment, the hydroxide to aluminum molar ratio is 2.1 : 1 to 2.6: 1.
[0049] In one embodiment, the inorganic base can be at least one base chosen from metal hydroxides, calcium hydroxide, magnesium hydroxide, strontium hydroxide, barium hydroxide, stannous hydroxide, yttrium hydroxide, calcium oxide, magnesium oxide, strontium oxide, barium oxide, stannous oxide, yttrium oxide, calcium carbonate, magnesium carbonate, strontium carbonate, barium carbonate, stannous carbonate, and yttrium carbonate.
[0050] Optionally, a buffer can be included. Buffers that can be used can be chosen from amino acids, such as glycine, betaine, such as betaine monohydrate, and quats. The buffer to aluminum molar ratio in certain embodiments can be at least 0.1 : 1 , or 0.1 : 1 to 3 : 1. In another embodiment, the buffer to aluminum molar ratio is 0.1 : 1 to 2: 1.
[0051] In one embodiment, the inorganic base is calcium hydroxide. In one such embodiment, the addition of calcium hydroxide provides an aqueous solution having a Ca(OH)2: glycine molar ratio of at least 0.1 : 1.
[0052] When a buffer is absent, significant Peak 3 species in the SEC chromatogram begin to form when the total Al concentration is above 0.2M. When a buffer is present, the total Al concentration can reach up to 2.5M while maintaining a predominant Peak 4 in the SEC chromatogram. In one embodiment, an aqueous aluminum chloride salt solution is buffered with glycine and held at 50°C to 95°C under vigorous stirring for a period time of 1 to 6 hours. To the heated solution, an aqueous solution of an inorganic base is added dropwise over a period of time of 1 to 3 hours while maintaining the aluminum-glycine solution at 50°C to 95°C under vigorous stirring. In one such embodiment, the solution has a glycine to aluminum molar ratio of 1.5. In another such embodiment, the solution has a glycine to aluminum molar ratio of 0.5.
[0053] In some embodiments, a zirconium salt may also be added to the pH adjusted aluminum salt solution. In one other such embodiment, the molar ratio of Al : Zr is 5 : 1 to 10 : 1. The zirconium salt may be simple Zr salts: ZrOCl2-8H20 or Oxo-Hexameric Zirconium-Octaamino Acid. In one such embodiment, the molar ratio of Al: Zr is 8. In another such embodiment, the molar ratio of Al: Zr is 7. In one other such embodiment, the molar ratio of Al: Zr is 9. [0054] For the above methods, the aluminum chloride salt and inorganic base may be obtained from a variety of sources. In one embodiment, the aluminum chloride salt includes aluminum trichloride, acidified aluminum chlorohexahydrate, aluminum dichlorohydrate, and aluminum monochlorohydrate. In one such embodiment, the aluminum chloride salt is aluminum chlorohexahydrate .
[0055] The present invention provides for aluminum compositions and/or aluminum-zirconium compositions having high levels of low molecular weight Al and Zr species. The high levels of low molecular weight Al and Zr species is reflected in a SEC trace that has an intense Peak 4 and low Peaks 1, 2, 3 and 5. The polymerization of the aluminum species in aqueous solutions and the correspondent gelation process are followed by monitoring the molecular weight profile of the polyoxohalides in time by SEC. The relative retention time ("Kd") for each of these peaks varies depending on the experimental conditions, but the peaks remain relative to each other. The SEC data for the examples is obtained using an SEC chromatogram using the following parameters: Waters®600 analytical pump and controller, Rheodyne® 77251 injector, Protein- Pak® 125 (Waters) column, Waters 2414 Refractive Index Detector. 5.56mM nitric acid mobile phase, 0.50ml/min flow rate, 2.0 microliter injection volume. Data was analyzed using Waters® Empower software (Waters Corporation, Milford, Mass.). The concentration of the aluminum species in aqueous solution does not affect the retention time in the machine.
[0056] The levels of the species corresponding to these peaks are estimated based on the following ratios (or percentages):
Pi
fPi = - i = l , 2, 3, 4, 5; ; = 2, 3, 4, 5
where fpi is the fraction of peak i, and Pi or Pj are the intensity of peaks Pi or Pj, respectively. The amount of low molecular weight Al species will be correlated with the fraction, fP4, or percentage, fP4 xlOO, of SEC-Peak 4. In brief, a preferred aluminum species would have a very low fpi , fp2, fp3, and/or fP5, and a high fP4.
[0057] In certain embodiments, the ratio of Peak 4 to Peak 3 is at least 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, or any number up to infinity. Preferably, Peak 3 is so low as to be undetectable. [0058] In one embodiment, an aluminum salt and/or aluminum-zirconium salt, in aqueous solution, exhibit a SEC profile wherein the SEC Peak 4 to Peak 3 intensity ratio is even as high as infinity, because the Peak 3 is undetectable. In some embodiments, the percentage of SEC Peak 4 of a total area of Peaks 1, 2, 3, 4 and 5 in the SEC chromatogram is: at least at least 90%; at least 95%, or 95 to 100%. In another such embodiment, the SEC Peak 4 area is 100%.
[0059] In another embodiment, the aluminum salt and/or the aluminum-zirconium salt, in aqueous solution, exhibits a SEC profile which exhibits low percentage of SEC Peak 3. In such embodiments, the composition has the percentage of SEC Peak 3 area of a total area of Peaks 1, 2, 3, 4 and 5 in the SEC chromatogram is: less than 5 %; less than 2 %; less than 1 %; less than 0.9 %; less than 0.8 %; less than 0.7 %; less than 0.6 %; of less than 0.5 %; less than 0.4 %; less than 0.3 %; less than 0.2 %; or less than 0.1 %. In another such embodiment, the composition has no SEC Peak 3 area.
[0060] In another embodiment, the aluminum salt and/or the aluminum-zirconium salt, in aqueous solution, exhibits a SEC profile which exhibits low percentages of SEC Peak 5. In such embodiments, the percentage of SEC Peak 5 area of a total area of Peaks 1, 2, 3, 4 and 5 in the SEC chromatogram is: less than 5 %; or less than 1 %. In another such embodiment, the composition has no SEC Peak 5 area.
[0061] In other embodiments, the aluminum salt and/or the aluminum-zirconium salt, in aqueous solution, exhibits a SEC profile which exhibits a low percentage of SEC Peak 1 and a low percentage of SEC Peak 2. In such embodiments, the percentage of SEC Peak 1 area of a total area of Peaks 1, 2, 3, 4 and 5 in the SEC chromatogram is less than 5 %; less than 2 %; or less than 1 %, or the salt has no SEC Peak 1 area. In other embodiments, the percentage of SEC Peak 2 area of a total area of Peaks 1, 2, 3, 4 and 5 in the SEC chromatogram is less than 5 %; less than 2 % or less than 1 %; or the salt has no SEC Peak 2 area. Preferably, the salt has no Peak 1 area and no Peak 2 area. More preferably, the salt has no Peak 1 area, no Peak 2 area and no Peak 3 area. Yet more preferably, the salt has no Peak 1 area, no Peak 2 area, no Peak 3 area and no Peak 5 area.
[0062] The compositions of this invention may be used to formulate many different aluminum containing materials. Examples include, but are not limited to, antiperspirant salts, water treatment, wastewater treatment, and clay pillaring.
[0063] The present invention is exemplified by the following non-limiting Examples. EXAMPLES
[0064] Two materials prepared in accordance with PCT/US2010/55030 are provided. The materials are aqueous systems that contain the glycine buffer and the calcium chloride byproduct of the manufacturing process.
27
[0065] The raw integration values for Al NMR spectroscopy peaks for these materials are listed below in Table 1, and Table 2 shows the relative abundance. The materials are analyzed by taking a 1 M solution and diluting in a 1 :4 ratio using D20. The final Al concentration for all
27
samples is 0.25M. The samples are analyzed at a Al resonance frequency of 104.2 MHz at 90°C. A coaxial insert containing NaA102 is included to provide a reference resonance peak at 80ppm. The instrument collects 1500 transients, with a pulse width of 6.4μ8 and a delay time of 2 seconds. The data for the relevant peaks are shown in the tables below. The full spectrographs can be seen in Figures 1 to 4.
[0066] Material 1 is held at reflux for 30 days at 100°C. Material 2 is subjected to 100°C for 5 days in an isochoric reaction vessel. For comparative purposes, the following discussion relates only with the relative integrations instead of raw data.
[0067] For Material 1, the AI30 signal (encompassing 96.10% of the total visible tetrahedral Al) is converted to a signal at 76 ppm (97.76% Td Al). Also, the amount of AI13 is reduced from 3.90% to 2.24%.
[0068] For Material 2, the AI30 signal at 70 ppm (encompassing 98.44% of the total visible tetrahedral Al) is converted to a signal at 76 ppm (99.37% Td Al). Also, the amount of AI13 is reduced from 1.56% to 0.63%.
TABLE 1
Figure imgf000014_0001
Table 2
Figure imgf000014_0002
Material 2 Treated 99.37 0 0.63
[0069] As used throughout, ranges are used as shorthand for describing each and every value that is within the range. Any value within the range can be selected as the terminus of the range. In addition, all references cited herein are hereby incorporated by referenced in their entireties. In the event of a conflict in a definition in the present disclosure and that of a cited reference, the present disclosure controls.
[0070] Unless otherwise specified, all percentages and amounts expressed herein and elsewhere in the specification should be understood to refer to percentages by weight. The amounts given are based on the active weight of the material.

Claims

CLAIMS WHAT IS CLAIMED IS:
1. A composition comprising a polyhydroxyoxoalummum cation detectable at 76 ppm by 27 Al NMR that is present in a relative abundance on a 27 Al NMR spectrograph that is greater than any other polyhydroxyoxoalummum cation detectable by 27 Al NMR.
2. The composition of claim 1, wherein the species of polyhydroxyoxoalummum cation detectable at 76 ppm by 27 Al NMR is present in a relative abundance on a 27 Al NMR spectrograph that is at least 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 96, 97, 98, 99, 99.5, 99.9, 99.99, or 99.999% of all species of polyhydroxyoxoalummum cation detectable by 27 Al NMR.
3. The composition of any foregoing claim, further comprising a buffer, wherein a molar ratio of buffer to aluminum is at least 0.1 : 1 , or optionally 0.1 : 1 to 3 : 1.
4. The composition of claim 3, wherein the buffer is at least one buffer chosen from an amino acid, betaine, and quat.
5. The composition of claim 4, wherein the buffer is an amino acid and a molar ratio of amino acid to aluminum is at least 0.1, optionally the amino acid is glycine.
6. The composition of any foregoing claim, wherein the composition further comprises zirconium.
7. The composition of claim 6, wherein a molar ratio of aluminum to zirconium is 5 : 1 to 10: 1.
8. A method of making a polyhydroxyoxoalummum cation detectable at 76 ppm by 27 Al NMR comprising:
heating an aqueous solution containing i) a first aluminum salt containing an AI30 polyhydroxyoxoalummum cation, ii) an inorganic salt, and iii) a buffer, wherein the buffer is at least one of an amino acid, betaine, and quat, and a molar ratio of buffer to aluminum is at least 0.1 :1, wherein the heating is one of
a) at a temperature of 100°C to 250°C in an isochoric reactor or under hydrothermal reaction for a time sufficient to form a species of polyhydroxyoxoalummum cation detectable at 76 ppm by 27 Al NMR; or
b) at 100°C at reflux for about 10 days or greater, optionally about 30 days or
greater.
9. A method of making a polyhydroxyoxoaluminum cation detectable at 76 ppm by Al NMR comprising storing an aqueous solution containing i) an AI30
polyhydroxyoxoaluminum cation, ii) an inorganic salt, and iii) a buffer, wherein the buffer is at least one of an amino acid, betaine, and quat, and a molar ratio of buffer to aluminum is at least 0.1 :1 at a temperature of 15°C to 60°C for a period of time until the polyhydroxyoxoaluminum cation detectable at 76 ppm by 27 Al NMR that is present in a relative abundance on a 27 Al NMR spectrograph that is greater than any other
polyhydroxyoxoaluminum cation detectable by 27 Al NMR.
10. The method of claim 9, wherein the storing is for at least 6 months, optionally at least one year.
11. The method of claim 8 or 9, wherein the inorganic salt is at least one chloride salt chosen from calcium chloride, strontium chloride, barium chloride, magnesium chloride, stannous chloride, and yttrium chloride.
12. The method of claim 8 or 9, wherein the buffer is glycine.
13. The method of claim 8 or 9, wherein the inorganic salt is calcium chloride and the buffer is glycine.
14. The method of claim 8, wherein heating in the isochoric reactor or under hydrothermal reaction is one of
i) at 100°C for about 5 days,
ii) at 120°C for about 12 hours, or
iii) at 150°C for about 20 minutes.
15. The method of any one of claims 8 to 14, wherein the composition further comprises zirconium.
16. The method of claim 15, wherein the zirconium compound is simple Zr salts,
ΖΓ0Ο2·8Η20 or Oxo-Hexameric Zirconium-Octaamino Acid.
17. Use of a heating step to convert AI30 polyhydroxyoxoaluminum cations in the species detectable by 27 Al NMR within an aqueous aluminum salt solution into a species of polyhydroxyoxoaluminum cation detectable at 76 ppm by 27 Al NMR, the heating step is one of: a) at a temperature of 100°C to 250°C in an isochoric reactor or under hydrothermal reaction for a time sufficient to form a species of polyhydroxyoxoaluminum cation detectable at 76 ppm by 27 Al NMR; or
b) at 100°C at reflux for about 10 days or greater, optionally about 30 days or
greater.
18. The use according to claim 17, wherein the aqueous aluminum salt solution i) has an aluminum to chloride molar ratio of 0.3: 1 to 3: 1; ii ) contains an inorganic salt, and iii) contains a buffer, wherein the buffer is at least one of an amino acid, betaine, and quat, and a molar ratio of buffer to aluminum is at least 0.1 : 1; an OH:Al molar ratio of at most 2.6: 1, or optionally, 2: 1 to 2.6: 1.
19. The use according to claim 18, wherein the buffer is glycine.
20. The use according to any one of claims 17 to 19, wherein the OH:Al molar ratio has been achieved by adding to the aqueous aluminum salt solution an inorganic base including at least one member chosen from calcium hydroxide, magnesium hydroxide, strontium hydroxide, barium hydroxide, stannous hydroxide, yttrium hydroxide, calcium oxide, magnesium oxide, strontium oxide, barium oxide, stannous oxide, yttrium oxide, calcium carbonate, magnesium carbonate, strontium carbonate, barium carbonate, stannous carbonate, and yttrium carbonate.
21. The use of claim 20, wherein the inorganic base is calcium hydroxide.
22. The use of any one of claims 17 to 21, wherein the OH to Al molar ratio is 2: 1 to 2.5: 1, or optionally 2.3: 1 to 2.5 : 1.
23. The use of any one of claims 17 to 22, wherein the aluminum salt is an aluminum
chloride compound chosen from aluminum trichloride, aluminum chlorohexahydrate, aluminum dichlorohydrate, and aluminum monochlorohydrate.
24. A composition produced by the method of any one of claims 8 to 16 or the use of any one of claims 17 to 23.
PCT/US2011/066018 2011-04-26 2011-12-20 Compositions containing polyhydroxyoxoaluminum cations and manufacture thereof WO2012148481A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
MX2013012371A MX361821B (en) 2011-04-26 2011-12-20 Compositions containing polyhydroxyoxoaluminum cations and manufacture thereof.
ES11810736.6T ES2569856T3 (en) 2011-04-26 2011-12-20 Compositions containing polyhydroxyoxuminium cations and manufacturing thereof
BR112013024919A BR112013024919A2 (en) 2011-04-26 2011-12-20 compositions containing polyhydroxy oxoaluminum cations and manufacture thereof
US14/110,723 US9174851B2 (en) 2011-04-26 2011-12-20 Compositions containing polyhydroxyoxoaluminum cations and manufacture thereof
CA2834129A CA2834129A1 (en) 2011-04-26 2011-12-20 Compositions containing polyhydroxyoxoaluminum cations and manufacture thereof
EP11810736.6A EP2702008B1 (en) 2011-04-26 2011-12-20 Compositions containing polyhydroxyoxoaluminum cations and manufacture thereof
AU2011366871A AU2011366871B2 (en) 2011-04-26 2011-12-20 Compositions containing polyhydroxyoxoaluminum cations and manufacture thereof
RU2013152256/05A RU2013152256A (en) 2011-04-26 2011-12-20 COMPOSITIONS CONTAINING POLYHYDROXYOXOALUMINUM CATION, AND THEIR PRODUCTION

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161479081P 2011-04-26 2011-04-26
US61/479,081 2011-04-26

Publications (1)

Publication Number Publication Date
WO2012148481A1 true WO2012148481A1 (en) 2012-11-01

Family

ID=45498118

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/066018 WO2012148481A1 (en) 2011-04-26 2011-12-20 Compositions containing polyhydroxyoxoaluminum cations and manufacture thereof

Country Status (12)

Country Link
US (1) US9174851B2 (en)
EP (1) EP2702008B1 (en)
AR (1) AR086120A1 (en)
AU (1) AU2011366871B2 (en)
BR (1) BR112013024919A2 (en)
CA (1) CA2834129A1 (en)
CL (1) CL2013003093A1 (en)
CO (1) CO6801753A2 (en)
ES (1) ES2569856T3 (en)
MX (1) MX361821B (en)
RU (1) RU2013152256A (en)
WO (1) WO2012148481A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016066527A1 (en) 2014-10-27 2016-05-06 Unilever Plc Anhydrous antiperspirant compositions
WO2017076562A1 (en) 2015-11-06 2017-05-11 Unilever Plc Antiperspirant compositions
US9775791B2 (en) 2013-05-20 2017-10-03 Conopco, Inc. Method of manufacture of antiperspirant salts
EP2999452B1 (en) 2013-05-20 2017-12-13 Unilever PLC Antiperspirant compositions
US9867765B2 (en) 2014-11-19 2018-01-16 Conopco, Inc. Antiperspirant compositions
US10098821B2 (en) 2014-11-19 2018-10-16 Conopco, Inc. Process of manufacture of an antiperspirant composition
US10117814B2 (en) 2014-10-27 2018-11-06 Conopco, Inc. Anhydrous antiperspirant aerosol compositions
US10682293B2 (en) 2015-11-06 2020-06-16 Conopco, Inc. Aerosol antiperspirant product

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006103092A1 (en) 2005-03-31 2006-10-05 Unilever Plc Process of preparing aluminium species
US20100055030A1 (en) 2006-11-27 2010-03-04 Naohiko Matsuda Reforming apparatus and method of operating the same

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991176A (en) 1973-11-23 1976-11-09 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with hydroxy carboxylic compounds
US3979510A (en) 1973-11-23 1976-09-07 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with complex aluminum buffers
GB2144992A (en) 1983-08-16 1985-03-20 Gillette Co Antiperspirants
US5358694A (en) 1986-01-08 1994-10-25 Westwood Chemical Corporation Method for preparing basic aluminum halides and product produced therefrom
US4871525A (en) 1986-10-24 1989-10-03 Westwood Chemical Corporation Antiperspirant composition and method of preparation
GB8619553D0 (en) 1986-08-11 1986-09-24 Unilever Plc Antiperspirants
AU597822B2 (en) 1987-05-15 1990-06-07 Unilever Plc Transparent antiperspirant stick compositions
US5330751A (en) 1988-04-14 1994-07-19 The Gilette Company Antiperspirant and method of making same
US5348720A (en) 1988-08-17 1994-09-20 The Mennen Company Basic aluminum antiperspirant active material having enhanced activity, antiperspirant active composition containing such material, and methods for preparation of such material and composition
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
US5725846A (en) 1995-03-02 1998-03-10 The Gillette Company Clear antiperspirant stick containing dibenzylidene alditol and hydroxyalkyl cellulose
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US5997850C1 (en) 1997-10-29 2001-11-27 Colgate Palmolive Co Antiperspirant actives and formulations made therefrom
US6682749B1 (en) 1998-04-03 2004-01-27 Colgate-Palmolive Company Low Residue cosmetic composition
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US5955065A (en) 1998-08-19 1999-09-21 The Gillette Company Antiperspirant compositions containing calcium salts
US6136302A (en) 1999-02-18 2000-10-24 The Procter & Gamble Company Process of making zirconium-aluminum antiperspirant active
ATE221766T1 (en) 1999-05-29 2002-08-15 Bk Giulini Chem Gmbh & Co Ohg METHOD FOR PRODUCING FINE PARTICULAR ANTIPERSPIRANT ACTIVE SUSPENSIONS
US6149897A (en) 1999-08-24 2000-11-21 The Procter & Gamble Company Process for making anhydrous compositions containing solubilized, enhanced antiperspirant active
US6451296B1 (en) 2000-02-01 2002-09-17 Zijun Li Enhanced efficacy aluminum-zirconium antiperspirants and methods for making
GB0012267D0 (en) 2000-05-19 2000-07-12 Unilever Plc Method pf prepatationof an antiperspirant salt
US6375937B1 (en) 2000-10-20 2002-04-23 Colgate-Palmolive Company Antiperspirant salts for enhanced cosmetic products
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
GB0100549D0 (en) 2001-01-09 2001-02-21 Unilever Plc Antiperspirant or deodorant compositions
US6342210B1 (en) 2001-04-20 2002-01-29 Colgate-Palmolive Company Antiperspirant actives from a glass form and products made therewith
US6765668B2 (en) 2002-01-10 2004-07-20 Chemimage, Inc. Method for detection of pathogenic microorganisms
US6726901B2 (en) 2002-05-09 2004-04-27 The Gillette Company Stabilized antiperspirant compositions containing aluminum-zirconium salts with low M:Cl ratio
US6835373B2 (en) 2002-07-12 2004-12-28 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
MXPA05001299A (en) 2002-08-02 2005-04-28 Gillette Co Clear personal care compositions containing visible capsules.
US20040091436A1 (en) 2002-11-12 2004-05-13 Zijun Li Antiperspirant compositions of enhanced efficacy containing strontium
US6936242B2 (en) 2002-11-15 2005-08-30 The Gillette Company Multi-portion antiperspirant composition
US20040198998A1 (en) 2003-04-04 2004-10-07 Marian Holerca Glycine-free antiperspirant salts with betaine for enhanced cosmetic products
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine
US6942850B2 (en) 2003-08-15 2005-09-13 The Gillette Company Aqueous alcoholic antiperspirant composition containing calcium enhanced antiperspirant salt
US6902724B1 (en) 2004-03-24 2005-06-07 Reheis, Inc. Enhanced efficacy basic aluminum halides, antiperspirant active compositions and methods for making
US7087220B2 (en) 2004-05-28 2006-08-08 Reheis, Inc. High pH antiperspirant compositions of enhanced efficacy
AU2004324474A1 (en) 2004-10-22 2006-05-04 Zijun Li Activated aluminum/depolymerized zirconium antiperspirant compositions
US8883129B2 (en) 2005-01-13 2014-11-11 The Procter & Gamble Company Enhanced efficacy antiperspirant active
US7704531B2 (en) 2005-02-18 2010-04-27 Colgate-Palmolive Company Enhanced efficacy aluminum or aluminum-zirconium antiperspirant salt compositions containing calcium salt(s) and betaine
US20060292098A1 (en) 2005-05-19 2006-12-28 Scavone Timothy A Consumer noticeable improvement in wetness protection
US20070003499A1 (en) 2005-06-30 2007-01-04 The Gillette Company Particulate enhanced efficacy antiperspirant salt with raised pH
US20070020211A1 (en) 2005-07-22 2007-01-25 Reheis, Inc. Betaine with Calcium and/or Strontium Antiperspirants
CL2006003116A1 (en) 2005-11-16 2008-02-29 Colgate Palmolive Co ANTI-TRANSPIRING COMPOSITION THAT INCLUDES AT LEAST ONE CHOSEN ALUMINUM SALT, ZIRCONY ALUMINUM, A COMPLEX ALUMINUM SALT OR A COMPLEX ALUMINUM-ZIRCONY SALT, A HYDROXIACIDE AND AN ACID COMPOUND OF QUATERNARY AMMONIUM; PROCESS TO PREPARE
US8801909B2 (en) 2006-01-06 2014-08-12 Nextchem, Llc Polymetal hydroxychloride processes and compositions: enhanced efficacy antiperspirant salt compositions
US20070196303A1 (en) 2006-02-17 2007-08-23 Reheis, Inc. Stable buffered aluminum compositions having high hplc bands iii and iv containing calcium/strontium
WO2008063188A2 (en) 2006-11-03 2008-05-29 Reheis, Inc. Betaine with calcium and/or strontium antiperspirants
US20080131354A1 (en) 2006-12-05 2008-06-05 Reheis, Inc. Polyaluminum calcium hydroxychlorides and methods of making the same
US20090016979A1 (en) 2007-07-09 2009-01-15 Zijun Li Aluminum and aluminum-zirconium compositions of enhanced efficacy containing reduced buffer and/or reduced zirconium
US20100202993A1 (en) 2007-12-12 2010-08-12 Long Pan Antiperspirant Active Compositions Having SEC Chromatogram Exhibiting High SEC Peak 4 Intensity
US20130209387A1 (en) 2010-11-02 2013-08-15 Colgate-Palmolive Company Antiperspirant Active Compositions and Manufacture Thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006103092A1 (en) 2005-03-31 2006-10-05 Unilever Plc Process of preparing aluminium species
US20100055030A1 (en) 2006-11-27 2010-03-04 Naohiko Matsuda Reforming apparatus and method of operating the same

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
ALLOUCHE L ET AL.: "Conversion of Al13 Keggin £ into Al3o: a reaction controlled by aluminum monomers", INORGANIC CHEMISTRY COMMUNICATIONS, vol. 6, 2003, pages 1167 - 1170
ALLOUCHE L ET AL.: "Conversion of Al13 Keggin epsilon into Al30: a reaction controlled by aluminum monomers", INORGANIC CHEMISTRY COMMUNICATIONS, vol. 6, 2003, pages 1167 - 1170, XP055023080 *
CASEY WH: "Large Aqueous Aluminum Hydroxide Molecules", CHEM. REV., vol. 106, no. 1, 2006, pages 1 - 16
CHEN Z ET AL.: "Effect of thermal treatment on the formation and transformation of Keggin A113 and Al30 species in hydrolytic polymeric aluminum solutions", COLLOIDS AND SURFACES A: PHYSIOCHEM. ENG. ASPECTS, vol. 292, 2007, pages 110 - 118, XP005808218, DOI: doi:10.1016/j.colsurfa.2006.06.005
DR. ALLAN; H. ROSENBERG: "Cosmetics and Toiletries Worldwide", vol. 252, 1993, HERTFORDSHIRE, UK: ASTON PUBLISHING GROUP, article "Antiperspirant Actives--Enhanced Efficacy Aluminum-Zirconium-Glycine (AZG) Salts", pages: 254 - 256
FU G ET AL.: "Aging Processes of Alumina Sol-Gels; Characterization of New Aluminum Polycations by 27Al NMR Spectroscopy", CHEM. MATER., vol. 3, no. 4, 1991, pages 602 - 610, XP001016004, DOI: doi:10.1021/cm00016a009
ROSWELL J ET AL.: "Speciation and Thermal Transformation in Alumina Sols; Structures of the Polyhydroxyoxoaluminum Cluster [Al3o O8 (OH)56 (H2O)26]18+ and its 8-Keggin Moiete", J. AM. CHEM. SOC., vol. 122, 2000, pages 3777 - 3778
SHAFRAN KL ET AL.: "The static anion exchange method for generation of high purity aluminum polyoxocations and monodisperse aluminum hydroxide nano-particles", J. MATER. CHEM., vol. 15, 2005, pages 3415 - 3423

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4321147A2 (en) 2013-05-20 2024-02-14 Unilever IP Holdings B.V. Antiperspirant compositions
US9775791B2 (en) 2013-05-20 2017-10-03 Conopco, Inc. Method of manufacture of antiperspirant salts
EP2999452B1 (en) 2013-05-20 2017-12-13 Unilever PLC Antiperspirant compositions
EP3295922A1 (en) 2013-05-20 2018-03-21 Unilever PLC Antiperspirant compositions
US10398633B2 (en) 2014-10-27 2019-09-03 Conopco, Inc. Anhydrous antiperspirant compositions
US10729627B2 (en) 2014-10-27 2020-08-04 Conopco, Inc. Anhydrous antiperspirant compositions
WO2016066527A1 (en) 2014-10-27 2016-05-06 Unilever Plc Anhydrous antiperspirant compositions
US10117814B2 (en) 2014-10-27 2018-11-06 Conopco, Inc. Anhydrous antiperspirant aerosol compositions
US10098821B2 (en) 2014-11-19 2018-10-16 Conopco, Inc. Process of manufacture of an antiperspirant composition
US9867765B2 (en) 2014-11-19 2018-01-16 Conopco, Inc. Antiperspirant compositions
US10632052B2 (en) 2015-11-06 2020-04-28 Conopco, Inc. Antiperspirant compositions
US10682293B2 (en) 2015-11-06 2020-06-16 Conopco, Inc. Aerosol antiperspirant product
WO2017076562A1 (en) 2015-11-06 2017-05-11 Unilever Plc Antiperspirant compositions

Also Published As

Publication number Publication date
RU2013152256A (en) 2015-06-10
MX2013012371A (en) 2014-02-03
US9174851B2 (en) 2015-11-03
AU2011366871B2 (en) 2014-10-30
BR112013024919A2 (en) 2016-12-20
EP2702008A1 (en) 2014-03-05
CA2834129A1 (en) 2012-11-01
AR086120A1 (en) 2013-11-20
US20140147405A1 (en) 2014-05-29
CO6801753A2 (en) 2013-11-29
EP2702008B1 (en) 2016-03-09
ES2569856T3 (en) 2016-05-12
CL2013003093A1 (en) 2014-02-21
AU2011366871A1 (en) 2013-05-02
MX361821B (en) 2018-12-18

Similar Documents

Publication Publication Date Title
AU2011366871B2 (en) Compositions containing polyhydroxyoxoaluminum cations and manufacture thereof
US9717663B2 (en) Antiperspirant active compositions and manufacture thereof
EP2635353B1 (en) Aluminum salt containing high percentage of AL30
US9463985B2 (en) Aluminum salt containing high percentage of Al30
JP2007522260A (en) Highly effective aluminum-zirconium antiperspirant
Pappas et al. Aluminum salt containing high percentage of Al 30
WO2001089994A1 (en) Method of preparation of an antiperspirant salt

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11810736

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2011366871

Country of ref document: AU

Date of ref document: 20111220

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 13248917

Country of ref document: CO

Ref document number: 2011810736

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2834129

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/A/2013/012371

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2013003093

Country of ref document: CL

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2013152256

Country of ref document: RU

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013024919

Country of ref document: BR

WWE Wipo information: entry into national phase

Ref document number: 14110723

Country of ref document: US

ENP Entry into the national phase

Ref document number: 112013024919

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20130927